| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H36O15 |
| Molecular Weight | 624.5871 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 11 / 11 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1OC)[C@@H]2CC(=O)C3=C(O)C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O2
InChI
InChIKey=GUMSHIGGVOJLBP-SLRPQMTOSA-N
InChI=1S/C29H36O15/c1-11-22(32)24(34)26(36)28(41-11)40-10-20-23(33)25(35)27(37)29(44-20)42-13-7-14(30)21-15(31)9-17(43-19(21)8-13)12-4-5-16(38-2)18(6-12)39-3/h4-8,11,17,20,22-30,32-37H,9-10H2,1-3H3/t11-,17-,20+,22-,23+,24+,25-,26+,27+,28+,29+/m0/s1
Methyl hesperidin is a flavanone-type flavonoid and a methylated derivative of hesperidin. It exhibits better bioactivities and water-solubility than hesperidin. It could improve the permeability and integrity of the capillary lining and usually found in association with vitamin C to enhance its effect.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
Sample Use Guides
In a preclinical study, mice were treated with dietary concentrations of 0, 1.25 or 5% for 96 weeks.
Route of Administration:
Oral
SUBSTANCE RECORD
